No Data
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Express News | Predictive Oncology Announces Results Of Study Showing Long-Term Stability And Viability Of Over 150K Cryopreserved Patient Tumor Samples At Its Biobank
Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery
Predictive Oncology Inc. (NASDAQ:POAI) Is Expected To Breakeven In The Near Future
Predictive Oncology Analyst Ratings
H.C. Wainwright Initiates Predictive Oncology(POAI.US) With Buy Rating, Announces Target Price $3
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
